Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
Add more filters











Publication year range
1.
J Periodontol ; 89(4): 466-475, 2018 04.
Article in English | MEDLINE | ID: mdl-29683497

ABSTRACT

BACKGROUND: Testosterone is known to affect bone in physiological and pathological conditions. The purpose of this study is to evaluate the role of testosterone in experimental periodontal disease in rats. METHODS: In this study we used a ligature model of periodontal disease in rats submitted to orchiectomy (OCX, testosterone depletion) with and without testosterone replacement therapy (TR). Control animals were sham-operated and retained physiological testosterone levels. Sixty-two days after orchiectomy and sham operations, ligatures were placed around the lower first molars for 2 weeks to induce experimental periodontal disease. Negative control animals received no ligatures. The outcomes assessed in the periodontal tissues were: inflammatory cytokine expression by enzyme-linked immunosorbent assay (ELISA), stereometric analysis of the inflammatory process and quantitation of inflammatory bone resorption by microcomputed tomography (µ-CT). RESULTS: The OCX+TR group showed the greatest increase in fibroblastic cells and blood vessels with reduced inflammatory cell numbers in the gingival tissue with induction of periodontal disease. There were no significant differences between OCX and Sham-operated groups in all the stereometric parameters assessed. Ligature placement induced inflammatory bone resorption, which was significantly attenuated in OCX animals. Experimental periodontitis induced a significant increase in interleukin (IL)-1ß, but the lowest levels were observed in the periodontitis/OCX group. IL-6 levels were not affected by OCX, but were significantly reduced in OCX+TR animals. CONCLUSION: The findings of the present study suggest that testosterone depletion attenuates inflammatory bone resorption in ligature-induced periodontitis, which may be partly mediated via decreased production of IL-1ß.


Subject(s)
Alveolar Bone Loss , Periodontitis , Animals , Disease Models, Animal , Rats , Testosterone , X-Ray Microtomography
2.
Innate Immun ; 22(8): 598-611, 2016 11.
Article in English | MEDLINE | ID: mdl-27605548

ABSTRACT

NOD2 is a member of the NLR family of proteins that participate in the activation of the innate immune response. RIP2 is a downstream kinase activated by both NOD1 and NOD2. There is scarcity of information regarding the relevance of NOD2 in periodontitis, a chronic inflammatory condition characterized by inflammatory bone resorption. We used NOD2-KO and RIP2-KO mice in a model of microbial-induced periodontitis. Heat-killed Aggregatibacter actinomycetemcomitans was injected in the gingival tissues three times/wk for 4 wk. Bone resorption was assessed by µCT analysis; osteoclasts were identified by immunohistochemical staining for TRAP and inflammation was assessed using a severity score system in H/E-stained sections. In vitro studies using primary macrophages assessed the response macrophages using qPCR-based array and multi-ligand ELISA. Bone resorption and osteoclastogenesis were significantly reduced in NOD2-KO mice. Severity of inflammation was not affected. qPCR-focused arrays and multi-ligand ELISA showed that expression of pro-inflammatory mediators was reduced in NOD2- and RIP2-deficient cells. RANKL-induced osteoclastogenesis was impaired in NOD2- and RIP2-deficient macrophages. We conclude that NOD2 is important for osteoclast differentiation and inflammatory bone resorption in vivo and also for the macrophage response to Gram-negative bacteria.


Subject(s)
Bone Resorption/immunology , Gram-Negative Bacterial Infections/immunology , Macrophages/physiology , Nod2 Signaling Adaptor Protein/metabolism , Osteogenesis/immunology , Periodontitis/immunology , Receptor-Interacting Protein Serine-Threonine Kinases/metabolism , Animals , Cell Differentiation , Cells, Cultured , Gene Expression Regulation , Inflammation Mediators/metabolism , Macrophages/microbiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Nod2 Signaling Adaptor Protein/genetics , RANK Ligand/metabolism , Receptor-Interacting Protein Serine-Threonine Kinase 2 , Receptor-Interacting Protein Serine-Threonine Kinases/genetics
3.
Food Funct ; 7(6): 2675-81, 2016 Jun 15.
Article in English | MEDLINE | ID: mdl-27182608

ABSTRACT

The flavanones hesperidin, eriocitrin and eriodictyol were investigated for their prevention of the oxidative stress and systemic inflammation caused by high-fat diet in C57BL/6J mice. The mice received a standard diet (9.5% kcal from fat), high-fat diet (45% kcal from fat) or high-fat diet supplemented with hesperidin, eriocitrin or eriodictyol for a period of four weeks. Hesperidin, eriocitrin and eriodictyol increased the serum total antioxidant capacity, and restrained the elevation of interleukin-6 (IL-6), macrophage chemoattractant protein-1 (MCP-1), and C-reactive protein (hs-CRP). In addition, the liver TBARS levels and spleen mass (g per kg body weight) were lower for the flavanone-treated mice than in the unsupplemented mice. Eriocitrin and eriodictyol reduced TBARS levels in the blood serum, and hesperidin and eriodictyol also reduced fat accumulation and liver damage. The results showed that hesperidin, eriocitrin and eriodictyol had protective effects against inflammation and oxidative stress caused by high-fat diet in mice, and may therefore prevent metabolic alterations associated with the development of cardiovascular diseases in other animals.


Subject(s)
Citrus/chemistry , Flavanones/pharmacology , Inflammation/drug therapy , Oxidative Stress/drug effects , Animals , Blood Glucose/metabolism , C-Reactive Protein/metabolism , Chemokine CCL2/blood , Chemotactic Factors/blood , Cholesterol/blood , Cytokines/blood , Diet, High-Fat/adverse effects , Hesperidin/pharmacology , Liver/drug effects , Liver/metabolism , Macrophages/drug effects , Macrophages/metabolism , Male , Mice , Mice, Inbred C57BL , Protective Agents/analysis , Protective Agents/pharmacology , Spleen/drug effects , Spleen/metabolism , Thiobarbituric Acid Reactive Substances/metabolism , Triglycerides/blood
4.
J Cell Biochem ; 116(5): 787-96, 2015 May.
Article in English | MEDLINE | ID: mdl-25510836

ABSTRACT

Curcumin has therapeutic potential in preventing several types of cancer, including colon, liver, prostate, and breast. The goal of this study was to evaluate the chemopreventive activity of systemically administered curcumin on oral carcinogenesis induced by 4-nitroquinolone-1-oxide (4-NQO). A total of 50 male albino rats, Rattus norvegicus, (Holtzman), were divided into five groups (n = 10 per group). Four of these groups were exposed to 50 ppm 4-NQO in their drinking water ad libitum for 8 or 12 weeks, two groups were treated with curcumin by oral gavage at 30 or 100 mg/kg per day, and one group was treated with corn oil (vehicle) only. The negative control group was euthanized at baseline. Tongues of all animals were removed after euthanasia and used in the subsequent analysis because the tongue is the primary site of carcinogenesis in this model. Descriptive histological analysis and immunohistochemistry for PCNA, Bcl-2, SOCS1 e-3, and STAT3 were performed to assess the oncogenic process. The gene expression of Vimentin, E-cadherin, N-cadherin, or TWIST1 was assessed using RT-qPCR as a representative of epithelial-mesenchymal transition (EMT) events. The administration of curcumin at 100 mg/kg during the 12 weeks markedly decreased the expression of PCNA, Bcl-2, SOCS1 e -3, and STAT3. Curcumin also minimized the cellular atypia under microscopic analysis and diminished the expression of the genes associated with EMT. These findings demonstrate that the systemic administration of curcumin has chemopreventive activity during oral carcinogenesis induced by 4-NQO.


Subject(s)
Antineoplastic Agents/therapeutic use , Curcumin/therapeutic use , Mouth Neoplasms/prevention & control , 4-Nitroquinoline-1-oxide/metabolism , Animals , Antineoplastic Agents/pharmacology , Biomarkers, Tumor/genetics , Carcinogens/metabolism , Corn Oil/therapeutic use , Curcumin/pharmacology , Disease Models, Animal , Epithelial Cells , Epithelial-Mesenchymal Transition/drug effects , Gene Expression/drug effects , Male , Mouth Neoplasms/chemically induced , Mouth Neoplasms/drug therapy , Quinolones/metabolism , Rats , Tongue/pathology
5.
PLoS One ; 9(8): e105172, 2014.
Article in English | MEDLINE | ID: mdl-25121974

ABSTRACT

Concomitant use of anabolic androgenic steroids and cocaine has increased in the last years. However, the effects of chronic exposure to these substances during adolescence on cardiovascular function are unknown. Here, we investigated the effects of treatment for 10 consecutive days with testosterone and cocaine alone or in combination on basal cardiovascular parameters, baroreflex activity, hemodynamic responses to vasoactive agents, and cardiac morphology in adolescent rats. Administration of testosterone alone increased arterial pressure, reduced heart rate (HR), and exacerbated the tachycardiac baroreflex response. Cocaine-treated animals showed resting bradycardia without changes in arterial pressure and baroreflex activity. Combined treatment with testosterone and cocaine did not affect baseline arterial pressure and HR, but reduced baroreflex-mediated tachycardia. None of the treatments affected arterial pressure response to either vasoconstrictor or vasodilator agents. Also, heart to body ratio and left and right ventricular wall thickness were not modified by drug treatments. However, histological analysis of left ventricular sections of animals subjected to treatment with testosterone and cocaine alone and combined showed a greater spacing between cardiac muscle fibers, dilated blood vessels, and fibrosis. These data show important cardiovascular changes following treatment with testosterone in adolescent rats. However, the results suggest that exposure to cocaine alone or combined with testosterone during adolescence minimally affect cardiovascular function.


Subject(s)
Cardiovascular System/drug effects , Cocaine/toxicity , Testosterone/toxicity , Animals , Blood Pressure/drug effects , Cocaine/administration & dosage , Heart Rate/drug effects , Male , Rats , Rats, Wistar , Testosterone/administration & dosage
6.
Immunol Invest ; 43(4): 370-90, 2014.
Article in English | MEDLINE | ID: mdl-24484374

ABSTRACT

Toll-like receptors (TLRs) play an important role in immunity, since they bind to pathogen surface antigens and initiate the immune response. However, little is known about the role of TLR-2 in the recognition of S. schenckii and in the subsequent immune response. Therefore, the aim of this study was to evaluate the involvement of TLR-2 in the immune response induced by S. schenckii. C57BL/6 mice (WT) and C57BL/6 TLR-2 knockout (TLR-2-/-) were used to evaluate, over a period of 10 weeks of sporotrichotic infection, the influence of TLR-2 over macrophages production of IL-1ß, IL-12 and TNF-α, their stimulation level by NO release and the production of IFN -γ, IL-6, IL-17 and TGF-ß by spleen cells. The results showed that the production of pro-inflammatory mediators and NO, TLR-2 interference is striking, since its absence completely inhibited it. IL-17 production was independent of TLR-2. The absence of Th1 response in TLR2-/- animals was concomitant with IL-17 production. Therefore, it can be suggested that TLR-2 absence interferes with the course of the infection induced by the fungus S. schenckii.


Subject(s)
Sporothrix/immunology , Sporotrichosis/immunology , Sporotrichosis/metabolism , Toll-Like Receptor 2/metabolism , Animals , Cytokines/biosynthesis , Disease Models, Animal , Female , Humans , Interleukin-12/biosynthesis , Interleukin-1beta/biosynthesis , Macrophages, Peritoneal/immunology , Macrophages, Peritoneal/metabolism , Mice , Mice, Knockout , Nitric Oxide/metabolism , Organ Size , Spleen/metabolism , Spleen/pathology , Toll-Like Receptor 2/genetics , Tumor Necrosis Factor-alpha/biosynthesis
7.
J Clin Periodontol ; 41(3): 295-302, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24433307

ABSTRACT

AIM: We hypothesized that platelet inactivation induced by drugs might interfere with periodontal repair in experimental periodontitis by suppressing the release of biological mediators from platelets at the site of injury. MATERIAL AND METHODS: Sixty rats were randomly assigned to six groups (n = 10) and ligatures were placed around lower first molars of three groups. The other three groups were used as negative controls. Ligatures were removed after 10 days of periodontitis induction and all groups were submitted to treatment with aspirin (Asp) (30 mg/kg), clopidogrel (Clop) (75 mg/kg) or NaCl 0.9% intra-gastrically once daily for 3 days. Periodontal tissue was assessed by the measurement of CXCL12, CXCL4, CCL5 and platelet-derived growth factor (PDGF) by enzyme-linked immunosorbent assay; histomorphometrical analysis of polymorphonuclear (PMN) infiltration, attachment loss, bone loss and osteoclast numbers and quantification of blood vessels by imunnohistochemistry. RESULTS: During periodontal repair and treatment with NaCl 0.9%, CCL5 was decreased and CXCL12 increased when compared with negative control groups. Asp and Clop did not affect CCL5 expression, decreased CXCL12 but only Clop decreased CXCL4 and PDGF content compared with saline-treated animals. Clop increased blood vessel number, reduced PMN count and decreased attachment and bone loss, also decreased osteoclast number in animals submitted or not to periodontal repair. CONCLUSION: Systemic administration of Clop for 3 days improved the repair process associated with experimental periodontal disease, suggesting that it may have therapeutic value under situations where tissues undergo a transition from inflammation to repair.


Subject(s)
Periodontitis/drug therapy , Periodontium/drug effects , Platelet Aggregation Inhibitors/therapeutic use , Ticlopidine/analogs & derivatives , Alveolar Bone Loss/drug therapy , Animals , Aspirin/administration & dosage , Aspirin/therapeutic use , Cell Count , Chemokine CCL5/drug effects , Chemokine CXCL12/drug effects , Clopidogrel , Infusions, Parenteral , Male , Microvessels/drug effects , Neutrophil Infiltration/drug effects , Neutrophils/drug effects , Osteoclasts/drug effects , Periodontal Attachment Loss/drug therapy , Platelet Aggregation Inhibitors/administration & dosage , Platelet Factor 4/drug effects , Platelet-Derived Growth Factor/drug effects , Random Allocation , Rats , Rats, Sprague-Dawley , Sodium Chloride , Ticlopidine/administration & dosage , Ticlopidine/therapeutic use
8.
J Periodontol ; 85(4): e72-81, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24059638

ABSTRACT

BACKGROUND: During inflammatory periodontal disease, peripheral blood mononuclear cells (PBMCs) are attracted to bone and differentiate into active bone-resorbing osteoclasts (OCs), thus providing evidence that the impact of chronic periodontitis (CP) on the activity of circulating mononuclear cells is of central importance. The authors test the hypothesis that peripheral blood mononuclear phagocytes (PBMPs) from patients with CP are activated and more susceptible to differentiation into OCs, which in turn would lead to more intense bone resorption. METHODS: In vitro cytokine production by both unstimulated and lipopolysaccharide-stimulated PBMCs from individuals with (n = 10) or without (n = 12) periodontitis was determined by cytokine array. OC differentiation from CD14(+) PBMCs was induced by receptor activator of nuclear factor-kappa B ligand (RANKL), either alone or in the presence of macrophage colony-stimulating factor (M-CSF). PBMC differentiation to OCs was confirmed by tartrate-resistant acid phosphatase staining; bone resorbing activity was assessed by using an osteologic plate assay (bone resorption pit formation). RESULTS: PBMCs from patients with CP produced tumor necrosis factor-α and higher amounts of interferon-γ, interleukin (IL)-1α, IL-1ß, IL-1rα, CXC motif chemokine 10, macrophage migration inhibitory factor, macrophage inflammatory protein (MIP)-1α, and MIP-1ß than the control cells. OC differentiation was induced by RANKL alone in PBMCs from patients with CP, but not in PBMCs from the healthy controls, which required the addition of M-CSF. In addition, PBMC-derived OCs from patients with CP showed significantly higher resorption activity than that observed in the healthy controls. Also, the circulating concentrations of M-CSF were significantly higher in patients with CP than in the control participants. CONCLUSIONS: These data indicate that in patients with CP, circulating PBMCs are primed for increased proinflammatory activity and that M-CSF plays a central role in this process by increasing OC formation and the consequent bone resorption activity.


Subject(s)
Chronic Periodontitis/blood , Osteoclasts/physiology , Phagocytes/physiology , Acid Phosphatase/analysis , Adult , Bone Resorption/pathology , Cell Culture Techniques , Cell Differentiation/drug effects , Cell Differentiation/physiology , Chemokine CCL3/analysis , Chemokine CCL4/analysis , Chemokine CXCL10/analysis , Chronic Periodontitis/pathology , Humans , Interferon-gamma/analysis , Interleukin 1 Receptor Antagonist Protein/analysis , Interleukin-1alpha/analysis , Interleukin-1beta/analysis , Isoenzymes/analysis , Lipopolysaccharide Receptors/analysis , Lipopolysaccharides/pharmacology , Macrophage Colony-Stimulating Factor/blood , Macrophage Colony-Stimulating Factor/pharmacology , Macrophage Migration-Inhibitory Factors/analysis , Male , Nitric Oxide/analysis , Osteoclasts/drug effects , Phagocytes/classification , Phagocytes/drug effects , RANK Ligand/pharmacology , Tartrate-Resistant Acid Phosphatase , Tumor Necrosis Factor-alpha/analysis
9.
Wound Repair Regen ; 21(3): 456-63, 2013.
Article in English | MEDLINE | ID: mdl-23627356

ABSTRACT

The lectin Artin M has been shown to accelerate the wound-healing process. The aims of this study were to evaluate the effects of Artin M on wound healing in the palatal mucosa of rats and to investigate the effects of Artin M on transforming growth factor beta (TGF-ß) and vascular endothelial growth factor (VEGF) secretion by rat gingival fibroblasts. A surgical wound was created on the palatal mucosa of 72 rats divided into three groups according to treatment: C--Control (nontreated), A--Artin M gel, and V--Vehicle. Eight animals per group were sacrificed at 3, 5, and 7 days postsurgery for histology, immunohistochemistry and determination of the levels of cytokines, and growth factors. Gingival fibroblasts were incubated with 2.5 µg/mL of Artin M for 24, 48, and 72 hours. The expression of VEGF and TGF-ß was determined by enzyme-linked immunosorbent assay. Histologically, at day 7, the Artin M group showed earlier reepithelialization, milder inflammatory infiltration, and increased collagen fiber formation, resulting in faster maturation of granular tissue than in the other groups (p < 0.05). Artin M-induced cell proliferation in vivo and promoted a greater expression of TGF-ß and VEGF in both experiments (p < 0.05). Artin M was effective in healing oral mucosa wounds in rats and was associated with increased TGF-ß and VEGF release, cell proliferation, reepithelialization, and collagen deposition and arrangement of fibers.


Subject(s)
Lectins/administration & dosage , Mouth Mucosa/injuries , Transforming Growth Factor beta/metabolism , Vascular Endothelial Growth Factor A/metabolism , Wound Healing/drug effects , Wounds and Injuries/drug therapy , Administration, Topical , Animals , Cell Proliferation , Cells, Cultured , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Fibroblasts/drug effects , Fibroblasts/metabolism , Fibroblasts/pathology , Immunohistochemistry , Male , Mouth Mucosa/drug effects , Mouth Mucosa/pathology , Rats , Rats, Wistar , Transforming Growth Factor beta/drug effects , Vascular Endothelial Growth Factor A/drug effects , Wounds and Injuries/metabolism , Wounds and Injuries/pathology
10.
Int J Exp Pathol ; 94(1): 65-73, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23317355

ABSTRACT

Osteonecrosis of the jaw (ONJ) following the use of bisphosphonates has become of increased interest in the scientific community, due in particular to its as-yet-unsolved pathogenesis. An experimental model of ONJ was induced in normal male rats [alendronate (ALN); 1 mg/Kg/day; n = 10] and matched controls (saline solution; n = 10). After 60 days of drug treatment, all animals were subjected to extractions of the left first lower molars and were euthanized at 3 and 28 days postsurgery. The following analyses were performed: (i) descriptive and quantitative (scores) histological evaluation, (ii) stereometry of distal sockets and (iii) biochemical measurement of C-telopeptide cross-linked collagen type I (CTX) and bone-specific alkaline phosphatase (BALP). The results showed that 28 days postsurgery the animals treated with ALN had areas of exposed and necrotic bone, associated with significant infection, especially in the interalveolar septum area and crestal regions, compared with controls. The levels of CTX, BALP and bone volume, as well as the degrees of inflammation and vascularization, were significantly reduced in these animals. Therefore, analysis of the data presented suggests that ALN therapy is associated with the development of osteonecrosis in the jaws of rodents after tooth extraction.


Subject(s)
Bisphosphonate-Associated Osteonecrosis of the Jaw/pathology , Jaw/pathology , Alendronate , Alkaline Phosphatase/metabolism , Animals , Biomarkers/metabolism , Bisphosphonate-Associated Osteonecrosis of the Jaw/etiology , Bisphosphonate-Associated Osteonecrosis of the Jaw/metabolism , Bone Remodeling , Collagen Type I/metabolism , Disease Models, Animal , Jaw/metabolism , Male , Molar/surgery , Orthognathic Surgical Procedures , Peptides/metabolism , Rats , Time Factors , Tooth Extraction/adverse effects , Weight Gain
11.
Immunol Invest ; 42(1): 36-48, 2013.
Article in English | MEDLINE | ID: mdl-23231043

ABSTRACT

Sporotrichosis is an infection caused by the dimorphic fungus Sporothrix schenckii. Toll-like receptors (TLRs) play an important role in immunity, since they bind to pathogen surface antigens and initiate the immune response. However, little is known about the role of TLR-2 and fungal surface antigens in the recognition of S. schenckii and in the subsequent immune response. This study aimed to evaluate the involvement of TLR-2 and fungal surface soluble (SolAg) and lipidic (LipAg) antigens in phagocytosis of S. schenckii and production of immune mediators by macrophages obtained from WT and TLR-2(-/-) animals. The results showed that TLR-2(-/-) animals had had statistical lower percentage of macrophages with internalized yeasts compared to WT. SolAg and LipAg impaired phagocytosis and immunological mediator production for both WT and TLR-2(-/-). The absence of TLR-2 led to lower production of the cytokines TNF-α, IL-1ß, IL-12 and IL-10 compared to WT animals. These results suggest a new insight in relation to how the immune system, through TLR-2, recognizes and induces the production of mediators in response to the fungus S. schenckii.


Subject(s)
Antigens, Fungal/immunology , Macrophages/immunology , Sporothrix/immunology , Sporotrichosis/immunology , Toll-Like Receptor 2/immunology , Animals , Cells, Cultured , Cytokines/metabolism , Female , Immunity, Innate , Inflammation Mediators/metabolism , Macrophages/microbiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Phagocytosis/immunology , Toll-Like Receptor 2/genetics
12.
PLoS One ; 7(9): e45197, 2012.
Article in English | MEDLINE | ID: mdl-23028842

ABSTRACT

BACKGROUND: Suppressor of cytokine signaling 3 (SOCS3) is an inducible endogenous negative regulator of signal transduction and activator of transcription 3 (STAT3). Epigenetic silencing of SOCS3 has been shown in head and neck squamous cell carcinoma (HNSCC), which is associated with increased activation of STAT3. There is scarce information on the functional role of the reduction of SOCS3 expression and no information on altered subcellular localization of SOCS3 in HNSCC. METHODOLOGY/PRINCIPAL FINDINGS: We assessed endogenous SOCS3 expression in different HNSCC cell lines by RT-qPCR and western blot. Immunofluorescence and western blot were used to study the subcellular localization of endogenous SOCS3 induced by IL-6. Overexpression of SOCS3 by CMV-driven plasmids and siRNA-mediated inhibition of endogenous SOCS3 were used to verify the role of SOCS3 on tumor cell proliferation, viability, invasion and migration in vitro. In vivo relevance of SOCS3 expression in HNSCC was studied by quantitative immunohistochemistry of commercially-available tissue microarrays. Endogenous expression of SOCS3 was heterogeneous in four HNSCC cell lines and surprisingly preserved in most of these cell lines. Subcellular localization of endogenous SOCS3 in the HNSCC cell lines was predominantly nuclear as opposed to cytoplasmic in non-neoplasic epithelial cells. Overexpression of SOCS3 produced a relative increase of the protein in the cytoplasmic compartment and significantly inhibited proliferation, migration and invasion, whereas inhibition of endogenous nuclear SOCS3 did not affect these events. Analysis of tissue microarrays indicated that loss of SOCS3 is an early event in HNSCC and was correlated with tumor size and histological grade of dysplasia, but a considerable proportion of cases presented detectable expression of SOCS3. CONCLUSION: Our data support a role for SOCS3 as a tumor suppressor gene in HNSCC with relevance on proliferation and invasion processes and suggests that abnormal subcellular localization impairs SOCS3 function in HNSCC cells.


Subject(s)
Carcinoma, Squamous Cell/genetics , Gene Expression Regulation, Neoplastic , Head and Neck Neoplasms/genetics , Neoplasm Invasiveness/genetics , STAT3 Transcription Factor/genetics , Suppressor of Cytokine Signaling Proteins/genetics , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Cell Line, Tumor , Cell Movement/genetics , Cell Nucleus/genetics , Cell Nucleus/metabolism , Cell Nucleus/ultrastructure , Cell Proliferation , Cytoplasm/genetics , Cytoplasm/metabolism , Cytoplasm/ultrastructure , Gene Silencing , Head and Neck Neoplasms/metabolism , Head and Neck Neoplasms/pathology , Humans , RNA, Small Interfering , STAT3 Transcription Factor/metabolism , Signal Transduction , Suppressor of Cytokine Signaling 3 Protein , Suppressor of Cytokine Signaling Proteins/metabolism
13.
ROBRAC ; 21(59)out.-dez. 2012. ilus
Article in Portuguese | LILACS | ID: lil-676593

ABSTRACT

Objetivo: Este estudo relata um caso incomum de parotidite aguda em um paciente adulto jovem, saudável e com boa higiene oral. Relato de Caso: O paciente procurou o Departamento de Estomatologia, na Universidade Estadual de Ponta Grossa devido a um inchaço na região da glândula parótida direita. O paciente foi submetido a exames clínicos e radiológicos e foi prescrito tratamentos com drogas anti-inflamatórias e antibióticos. No quinto dia os sinais e sintomas haviam desaparecido. Conclusão: O desenvolvimento de parotidite aguda em adultos jovens saudáveis com uma boa higiene oral é possível, mas isso torna o diagnóstico mais difícil. Anti-inflamatórios, antibióticos e fisioterapia associada com calor pode contribuir para a recuperação dos sinais e sintomas após 5 dias de tratamento.


Aim: This study reports an unusual case of acute parotitis in a healthy young adult with good oral hygiene. Case Report: The patient sought the Department of Stomatology, at Ponta Grossa State University due to a swollen on the right parotid gland region. The patient underwent clinical and radiological treatments and was prescribed anti-inflammatory drugs and antibiotics. On the fifth day the signs and symptoms had disappeared. Conclusion: The development of acute parotitis in healthy young adults with good oral hygiene is possible, but this makes the diagnosis more difficult. Anti-inflammatory, antibiotic and heat physiotherapy can contribute to the recovery of the signs and symptoms after 5 days of treatment.

14.
Arch Oral Biol ; 57(9): 1282-9, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22487693

ABSTRACT

OBJECTIVE: The aim of this study was to investigate the effects of PRP on SAOS-2 cells in terms of cytokine expression, cell activity and oxidative stress. DESIGN: Cell line SAOS-2 (1×10(5)cells/mL) were grown in culture medium α-MEM with 10% FBS for 24h and stimulated (or not) with PRP at concentrations of 3, 10 and 20%, LPS (E. coli, 10g/mL) and IL-1ß (1mg/mL) for 24h. The supernatant was collected and analyzed for the expression of cytokines in a panel array, ALP using a commercial kit and NO(2)(-) with Griess reaction method. Also, the cells were analyzed using Western blot for RANKL and slot blotting for nitrotyrosine expression. RESULT: There were no significant differences amongst the groups in terms of NO(2)(-), protein nitrotyrosine content and RANKL expression. However, all stimuli increased ALP activity and in case of PRP, it was in a dose-dependent manner (p<0.001). Also, all stimuli induced an increase in cytokines and chemokines expression, but only PRP promoted an increase of component C5, sICAM-1 and RANTES expression. Whilst IL-1 receptor antagonist (IL-1ra) expression was down-regulated by PRP, both LPS and IL-1ß caused up-regulation of this cytokine. CONCLUSIONS: PRP can stimulate osteoblast activity and cytokine/chemokine release, as well as indicate some of the mediators that can (and cannot) be involved in this activation.


Subject(s)
Alkaline Phosphatase/analysis , Cytokines/analysis , Osteoblasts/metabolism , Platelet-Rich Plasma/physiology , Cell Line, Tumor , Chemokine CCL5/analysis , Chemokine CXCL1/analysis , Complement C5/analysis , Dose-Response Relationship, Drug , Escherichia coli , Granulocyte-Macrophage Colony-Stimulating Factor/analysis , Humans , Intercellular Adhesion Molecule-1/analysis , Interleukin 1 Receptor Antagonist Protein/analysis , Interleukin-1beta/pharmacology , Interleukins/analysis , Lipopolysaccharides/pharmacology , Nitric Oxide/analysis , Osteoblasts/drug effects , Oxidative Stress/physiology , RANK Ligand/analysis , Tyrosine/analogs & derivatives , Tyrosine/analysis
15.
J Periodontol ; 83(11): 1432-9, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22309177

ABSTRACT

BACKGROUND: Testosterone is the primary male sexual hormone, and varying concentrations of the hormone mediated by physiologic, pathologic, or pharmacologic mechanisms may induce large variations in the body. Data regarding the general role of testosterone in mediating inflammation are still inconclusive. Therefore, the purpose of this study is to assess the consequences of supra- and subphysiologic levels of testosterone on ligature-induced bone loss in rats. METHODS: Three male adult Holtzman rats were used to observe the course of serum testosterone concentration following orchiectomy (Ocx) and testosterone injections. Another 60 rats were randomly assigned to the following groups: (1) sham-operation controls (n = 10); (2) sham-operation and ligature-induced bone loss (n = 10); (3) orchiectomy without ligature (Ocx; n = 10); (4) Ocx and ligature (n = 10); (5) Ocx plus 250 mg/kg body weight intramuscular testosterone esters injection without ligature (Ocx+T; n = 10); and (6) Ocx, T, and ligature (n = 10). The ligatures were placed 30 days postorchiectomy (or sham-operation) and maintained for 15 days. Thereafter, the rats were sacrificed, and their hemimandibles were used for radiographic evaluation of bone loss along with histologic and histometric analyses of gingival tissue. RESULTS: The results indicated a significant increase in bone loss in the Ocx and Ocx+T groups in the presence and absence of inflammation, respectively. In addition, the Ocx and Ocx+T groups presented increased gingival area accompanying ligature-induced bone loss. CONCLUSIONS: Both sub- and supraphysiologic testosterone levels may influence bone metabolism, but only subphysiologic levels significantly increase ligature-induced bone loss. Moreover, testosterone has a regulatory effect on the gingival area.


Subject(s)
Alveolar Bone Loss/metabolism , Testosterone/metabolism , Alveolar Bone Loss/diagnostic imaging , Alveolar Bone Loss/pathology , Animals , Ligation , Male , Orchiectomy , Pilot Projects , Radiography , Rats , Rats, Sprague-Dawley
16.
Innate Immun ; 18(1): 155-63, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21242275

ABSTRACT

Curcumin is a plant-derived dietary spice ascribed various biological activities. Curcumin therapeutic applications have been studied in a variety of conditions, but not on periodontal disease. Periodontal disease is a chronic inflammatory condition initiated by an immune response to micro-organisms of the dental biofilm. Experimental periodontal disease was induced in rats by injecting LPS in the gingival tissues on the palatal aspect of upper first molars (30 µg LPS, 3 times/week for 2 weeks). Curcumin was administered to rats daily via oral gavage at 30 and 100 mg/kg body weight. Reverse transcriptase-qPCR and ELISA were used to determine the expression of IL-6, TNF-α and prostaglandin E(2) synthase on the gingival tissues. The inflammatory status was evaluated by stereometric and descriptive analysis on hematoxylin/eosin-stained sections, whereas modulation of p38 MAPK and NK-κB signaling was assessed by Western blot. Curcumin effectively inhibited cytokine gene expression at mRNA and protein levels, but NF-κB was inhibited only with the lower dose of curcumin, whereas p38 MAPK activation was not affected. Curcumin produced a significant reduction on the inflammatory infiltrate and increased collagen content and fibroblastic cell numbers. Curcumin potently inhibits innate immune responses associated with periodontal disease, suggesting a therapeutic potential in this chronic inflammatory condition.


Subject(s)
Anti-Inflammatory Agents/administration & dosage , Curcumin/administration & dosage , Gingiva/drug effects , Periodontal Diseases/drug therapy , Administration, Oral , Animals , Anti-Inflammatory Agents/adverse effects , Cell Movement/drug effects , Cell Movement/immunology , Curcumin/adverse effects , Disease Models, Animal , Down-Regulation/drug effects , Down-Regulation/immunology , Gingiva/immunology , Gingiva/metabolism , Gingiva/pathology , Humans , Interleukin-6/genetics , Interleukin-6/metabolism , Intramolecular Oxidoreductases/genetics , Intramolecular Oxidoreductases/metabolism , Lipopolysaccharides/immunology , Male , NF-kappa B/metabolism , Periodontal Diseases/immunology , Prostaglandin-E Synthases , Rats , Rats, Inbred Strains , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
17.
J Periodontol ; 82(11): 1608-15, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21417589

ABSTRACT

BACKGROUND: Inflammatory stimuli activate inducible nitric oxide synthase (iNOS) in a variety of cell types, including osteoclasts (OC) and osteoblasts, resulting in sustained NO production. In this study, we evaluate the alveolar bone loss in rats with periodontitis under long-term iNOS inhibition, and the differentiation and activity of OC from iNOS-knockout (KO) mice in vitro. METHODS: Oral aminoguanidine (an iNOS inhibitor) or water treatment was started 2 weeks before induction of periodontitis. Rats were sacrificed 3, 7, or 14 days after ligature placement, and alveolar bone loss was evaluated. In vitro OC culture experiments were also performed to study the differentiation of freshly isolated bone marrow cells from both iNOS KO and wild-type C57BL/6 mice. OC were counted 6 days later after tartrate-resistant acid phosphatase staining (a marker of osteoclast identity), and bone resorption activity was assessed by counting the number of resorption pits on dentin disks. RESULTS: Rats with ligature showed progressive and significant alveolar bone loss compared to sham animals, and aminoguanidine treatment significantly inhibited ligature-induced bone loss at 7 and 14 days after the induction. In comparison to bone marrow cells from wild-type mice, cells from iNOS KO mice showed decreased OC growth and the resulting OC covered a smaller culture dish area and generated fewer resorption pit counts. CONCLUSION: Our results demonstrate that iNOS inhibition prevents alveolar bone loss in a rat model of ligature-induced periodontitis, thus confirming that iNOS-derived NO plays a crucial role in the pathogenesis of periodontitis, probably by stimulating OC differentiation and activity.


Subject(s)
Alveolar Bone Loss/enzymology , Nitric Oxide Synthase Type II/metabolism , Nitric Oxide/metabolism , Osteoclasts/metabolism , Periodontitis/complications , Alveolar Bone Loss/complications , Animals , Bone Resorption/complications , Bone Resorption/enzymology , Cells, Cultured , Enzyme Inhibitors/pharmacology , Guanidines/pharmacology , In Vitro Techniques , Male , Nitric Oxide Synthase Type II/drug effects , Osteoclasts/cytology , Periodontitis/metabolism , Rats , Rats, Wistar
18.
Cells Tissues Organs ; 194(5): 421-30, 2011.
Article in English | MEDLINE | ID: mdl-21293102

ABSTRACT

Treatment with tacrolimus (FK-506) has been shown to induce a significant decrease in the number of spermatocytes, spermatids, and Sertoli cells. Regarding the importance of the peritubular tissue for the maintenance of Sertoli cells, the integrity of the cellular and extracellular components of the peritubular tissue was evaluated in adult rats that were treated with 1 mg/kg/day of FK-506 for 30 and 60 days. Testicular sections were used for a quantitative analysis of the peritubular cells (PCs) and were submitted to the PAS method. Paraffin sections were submitted to the TUNEL method and to immunohistochemistry for the detection of caspase-3. Several testicular fragments were analyzed under a transmission electron microscope (TEM). A weak PAS reaction was noted in the peritubular tissue of the tacrolimus-treated animals. Next to the damaged peritubular tissue, the Sertoli cell nuclei were absent or dislocated from the basement membrane. In the treated animals, the number of PCs decreased significantly compared to the control animals, and these cells showed apoptotic features, were TUNEL positive, and were caspase-3 immunolabeled. Using the TEM, apoptosis was confirmed in myoid cells; moreover, the thickness and undulation of the basal laminae and an enlargement of the collagen I layer adjacent to the myoid cells was observed. Long-term treatment with the immunosuppressor induced peritubular myoid cell death by apoptosis and disarrangement of the peritubular extracellular layers. Future studies are necessary to confirm whether the structural alterations in the seminiferous epithelium are related to the effect of FK-506 on peritubular tissue.


Subject(s)
Immunosuppressive Agents/adverse effects , Sertoli Cells/drug effects , Tacrolimus/adverse effects , Testis/drug effects , Testis/pathology , Animals , In Situ Nick-End Labeling , Male , Rats , Seminiferous Tubules/drug effects , Seminiferous Tubules/pathology , Sertoli Cells/pathology
19.
Arch Oral Biol ; 56(1): 41-7, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20864089

ABSTRACT

OBJECTIVE: in this study we have assessed the renal and cardiac consequences of ligature-induced periodontitis in both normotensive and nitric oxide (NO)-deficient (L-NAME-treated) hypertensive rats. MATERIALS AND METHODS: oral L-NAME (or water) treatment was started two weeks prior to induction of periodontitis. Rats were sacrificed 3, 7 or 14 days after ligature placement, and alveolar bone loss was evaluated radiographically. Thiobarbituric reactive species (TBARS; a lipid peroxidation index), protein nitrotyrosine (NT; a marker of protein nitration) and myeloperoxidase activity (MPO; a neutrophil marker) were determined in the heart and kidney. RESULTS: in NO-deficient hypertensive rats, periodontitis-induced alveolar bone loss was significantly diminished. In addition, periodontitis-induced cardiac NT elevation was completely prevented by L-NAME treatment. On the other hand L-NAME treatment enhanced MPO production in both heart and kidneys of rats with periodontitis. No changes due to periodontitis were observed in cardiac or renal TBARS content. CONCLUSIONS: in addition to mediating alveolar bone loss, NO contributes to systemic effects of periodontitis in the heart and kidney.


Subject(s)
Free Radical Scavengers/antagonists & inhibitors , Hypertension/metabolism , Kidney/metabolism , Myocardium/metabolism , Nitric Oxide/antagonists & inhibitors , Periodontitis/metabolism , Alveolar Bone Loss/diagnostic imaging , Alveolar Bone Loss/metabolism , Animals , Disease Models, Animal , Enzyme Inhibitors/pharmacology , Heart/drug effects , Kidney/drug effects , Male , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Oxidative Stress/physiology , Periodontitis/diagnostic imaging , Peroxidase/analysis , Radiography , Rats , Rats, Wistar , Thiobarbituric Acid Reactive Substances/analysis , Tyrosine/analogs & derivatives , Tyrosine/analysis
20.
J Periodontol ; 82(5): 767-77, 2011 May.
Article in English | MEDLINE | ID: mdl-21073332

ABSTRACT

BACKGROUND: Platelets contain an array of biologic mediators that can modulate inflammation and repair processes including proinflammatory mediators and growth factors. Previous studies have shown that periodontitis and periodontal repair are associated with platelet activation. We hypothesized that drug-induced platelet inactivation may interfere in the processes of inflammation and repair in experimental periodontitis in rats by suppressing the release of biologic mediators from platelets to the site of injury. METHODS: To measure the effects on periodontitis, ligatures were placed around first molars, and aspirin (Asp, 30 mg/kg) or clopidogrel (Clo, 75 mg/kg) was given intragastrically once daily for 15 days. Interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and thromboxane A(2) levels were measured by enzyme-linked immunosorbent assay. To evaluate the effects of antiplatelet drugs on periodontal repair, ligatures were removed after 15 days of periodontitis induction, and Asp or Clo were administered beginning the following day for 15 days. Periodontal repair was assessed by microcomputed tomography. RESULTS: On periodontitis phase, Asp and Clo significantly reduced levels of TNF-α and Il-6 (P <0.05), but only Asp decreased thromboxane A(2) (P <0.05). Asp and Clo decreased inflammatory infiltration; however, this reduction was more pronounced with Clo treatment (P <0.05). Histometric analysis showed that Asp and Clo impaired alveolar bone resorption. During the repair phase and after removal of the ligatures, microcomputed tomography analysis demonstrated that treatment with Asp and Clo did not impair alveolar bone repair. CONCLUSION: Systemic administration of Asp and Clo attenuates the inflammation associated with periodontitis without affecting the repair process when stimulus is removed.


Subject(s)
Periodontitis/etiology , Periodontium/drug effects , Platelet Aggregation Inhibitors/therapeutic use , Alveolar Bone Loss/etiology , Alveolar Bone Loss/pathology , Alveolar Bone Loss/prevention & control , Animals , Aspirin/therapeutic use , Blood Platelets/drug effects , Bone Density/drug effects , Bone Regeneration/drug effects , Clopidogrel , Inflammation Mediators/analysis , Intercellular Signaling Peptides and Proteins/analysis , Interleukin-6/analysis , Leukocytes/drug effects , Male , Mandibular Diseases/etiology , Mandibular Diseases/pathology , Mandibular Diseases/prevention & control , Periodontal Attachment Loss/etiology , Periodontal Attachment Loss/pathology , Periodontal Attachment Loss/prevention & control , Periodontitis/pathology , Periodontitis/prevention & control , Periodontium/pathology , Platelet Activation/drug effects , Random Allocation , Rats , Rats, Sprague-Dawley , Thromboxane A2/analysis , Ticlopidine/analogs & derivatives , Ticlopidine/therapeutic use , Time Factors , Tumor Necrosis Factor-alpha/drug effects , Wound Healing/drug effects , X-Ray Microtomography
SELECTION OF CITATIONS
SEARCH DETAIL